Copy to clipboard 
Equifund is launching a Regulation Crowdfunding offering for Kleiner Device Labs (KDL), developer of patented devices designed to improve spinal surgical outcomes and help procedures be less painful and less expensive.
Regulation Crowdfunding (Reg-CF) allows eligible companies to offer and sell securities through crowdfunding. Reg-CF permits a company to raise a maximum aggregate amount of $5 million through crowdfunding offerings in a 12-month period.
KDL holds 23 U.S. patents, and has developed two primary pieces of equipment and implants available for use in the spine: KG1 and KG2.
The KG1 bone graft delivery tool is designed to avoid issues that may arise with use of round, end-dispensing funnels, such as cannula tip visualization, jamming, site injury and failure to distribute graft in the disc space.
KG1 reportedly increases the delivery of bone graft material by over 40%, and is currently being used in surgery centers across the U.S. KG1 launched in 2018.
The 3D-printed KG2 Solid State Fusion Cage is in development, and is being designed to simplify the bone graft delivery method while reducing the potential for operative complications.
Also in development is DragonTail, a single pass instrument that allows a 120º arc of endplate preparation and multiple tip options for increased access to the contralateral disk space.
KDL expects to file for FDA 510(k) clearance for KG2 in 2Q21, and approval under the CE Mark will likely be awarded in 4Q21.
“Back pain is something millions of people live with every day. The problem is that current surgical methods to relieve pain are complicated, risky, and invasive,” said Kleiner Device Labs Founder and CEO Dr. Jeffrey Kleiner. “Our patented technology greatly improves the surgical procedure for spinal fusion. We transform what is normally a complex, multi-step process into a simpler, single-step process that is minimally invasive with lower risk to the patient at a lower cost. Our system allows a good spinal surgeon to be even better.”
Equifund is launching a Regulation Crowdfunding offering for Kleiner Device Labs (KDL), developer of patented devices designed to improve spinal surgical outcomes and help procedures be less painful and less expensive.
Regulation Crowdfunding (Reg-CF) allows eligible companies to offer and sell securities through crowdfunding. Reg-CF...
Equifund is launching a Regulation Crowdfunding offering for Kleiner Device Labs (KDL), developer of patented devices designed to improve spinal surgical outcomes and help procedures be less painful and less expensive.
Regulation Crowdfunding (Reg-CF) allows eligible companies to offer and sell securities through crowdfunding. Reg-CF permits a company to raise a maximum aggregate amount of $5 million through crowdfunding offerings in a 12-month period.
KDL holds 23 U.S. patents, and has developed two primary pieces of equipment and implants available for use in the spine: KG1 and KG2.
The KG1 bone graft delivery tool is designed to avoid issues that may arise with use of round, end-dispensing funnels, such as cannula tip visualization, jamming, site injury and failure to distribute graft in the disc space.
KG1 reportedly increases the delivery of bone graft material by over 40%, and is currently being used in surgery centers across the U.S. KG1 launched in 2018.
The 3D-printed KG2 Solid State Fusion Cage is in development, and is being designed to simplify the bone graft delivery method while reducing the potential for operative complications.
Also in development is DragonTail, a single pass instrument that allows a 120º arc of endplate preparation and multiple tip options for increased access to the contralateral disk space.
KDL expects to file for FDA 510(k) clearance for KG2 in 2Q21, and approval under the CE Mark will likely be awarded in 4Q21.
“Back pain is something millions of people live with every day. The problem is that current surgical methods to relieve pain are complicated, risky, and invasive,” said Kleiner Device Labs Founder and CEO Dr. Jeffrey Kleiner. “Our patented technology greatly improves the surgical procedure for spinal fusion. We transform what is normally a complex, multi-step process into a simpler, single-step process that is minimally invasive with lower risk to the patient at a lower cost. Our system allows a good spinal surgeon to be even better.”
You’ve reached your limit.
We’re glad you’re finding value in our content — and we’d love for you to keep going.
Subscribe now for unlimited access to orthopedic business intelligence.
JV
Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.
